ReviewJournal of cardiovascular development and disease2026
Enlicitide, a Novel Oral Macrocyclic Peptide PCSK9 Inhibitor for Lipid Lowering: A Systematic Review and Meta-Analysis.
Burcu Yagmur et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.